← All Sponsors
SPONSOR

Shanghai Huaota Biopharmaceutical Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Hidradenitis Suppurativa
NCT06895499 Phase 1, Phase 2
Recruiting

Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.

Hidradenitis Suppurativa
China View Trial →